Bae W, Lee B, Kim H, Lee J, Chung I, Bum Cho S
Front Immunol. 2022; 13:879452.
PMID: 35720374
PMC: 9202498.
DOI: 10.3389/fimmu.2022.879452.
Li L, Yuan H, Yang Y, Wang L, Zou R
J Cancer. 2020; 11(18):5424-5431.
PMID: 32742489
PMC: 7391193.
DOI: 10.7150/jca.46308.
Johnston M, Khakoo S
World J Gastroenterol. 2019; 25(24):2977-2989.
PMID: 31293335
PMC: 6603808.
DOI: 10.3748/wjg.v25.i24.2977.
Kim D, Cho E, Bum Cho S, Choi S, Kim S, Yu J
Medicine (Baltimore). 2018; 97(42):e12866.
PMID: 30334999
PMC: 6211840.
DOI: 10.1097/MD.0000000000012866.
Hosseinzadeh F, Verdi J, Ai J, Hajighasemlou S, Seyhoun I, Parvizpour F
Cancer Cell Int. 2018; 18:133.
PMID: 30214375
PMC: 6131874.
DOI: 10.1186/s12935-018-0624-x.
KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
Yindom L, Mendy M, Bodimeade C, Chambion C, Aka P, Whittle H
PLoS One. 2017; 12(11):e0188307.
PMID: 29149205
PMC: 5693433.
DOI: 10.1371/journal.pone.0188307.
Correlation Between Natural Killer Cell Activity and Systemic Inflammatory Markers for Heterogeneous Cancer Patients Treated With Wheel Balance Cancer Therapy.
Kang H, Bae K, Kim J, Cho C, Yoo H
Integr Cancer Ther. 2017; 17(2):322-331.
PMID: 28714337
PMC: 6041908.
DOI: 10.1177/1534735417717789.
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.
Hoseini S, Cheung N
Cancer Lett. 2017; 399:44-52.
PMID: 28428075
PMC: 5496242.
DOI: 10.1016/j.canlet.2017.04.013.
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?.
Patel P, Schutzer S, Pyrsopoulos N
World J Gastrointest Pathophysiol. 2016; 7(3):242-55.
PMID: 27574562
PMC: 4981764.
DOI: 10.4291/wjgp.v7.i3.242.
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C, Sun H, Xiao W, Zhang C, Tian Z
Acta Pharmacol Sin. 2015; 36(10):1191-9.
PMID: 26073325
PMC: 4648180.
DOI: 10.1038/aps.2015.41.
Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.
Van Tong H, Huu Song L, Xuan Hoan N, Cuong B, Tien Sy B, Son H
BMC Infect Dis. 2015; 15:25.
PMID: 25626490
PMC: 4318451.
DOI: 10.1186/s12879-015-0754-x.
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Sun C, Sun H, Zhang C, Tian Z
Cell Mol Immunol. 2014; 12(3):292-302.
PMID: 25308752
PMC: 4654321.
DOI: 10.1038/cmi.2014.91.
Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.
Saito S, Harada Y, Morodomi Y, Onimaru M, Yoshida K, Kyuragi R
Hum Gene Ther Methods. 2013; 24(4):241-52.
PMID: 23885718
PMC: 3753730.
DOI: 10.1089/hgtb.2012.183.
Immunobiology of hepatocellular carcinoma.
Flecken T, Spangenberg H, Thimme R
Langenbecks Arch Surg. 2011; 397(5):673-80.
PMID: 21479622
DOI: 10.1007/s00423-011-0783-x.
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.
Gao B, Radaeva S, Park O
J Leukoc Biol. 2009; 86(3):513-28.
PMID: 19542050
PMC: 2735282.
DOI: 10.1189/JLB.0309135.
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.
Campoli M, Ferrone S
Oncogene. 2008; 27(45):5869-85.
PMID: 18836468
PMC: 2729106.
DOI: 10.1038/onc.2008.273.
Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection.
Sekiguchi T, Nagamine T, Takagi H, Mori M
World J Gastroenterol. 2006; 12(13):2089-94.
PMID: 16610063
PMC: 4087691.
DOI: 10.3748/wjg.v12.i13.2089.
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.
Ichim C
J Transl Med. 2005; 3(1):8.
PMID: 15698481
PMC: 549049.
DOI: 10.1186/1479-5876-3-8.
Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
Kim H, Park H, Park J, Kim S, Kim K, Kim J
Cancer Immunol Immunother. 2003; 53(5):461-70.
PMID: 14648068
PMC: 11034283.
DOI: 10.1007/s00262-003-0461-0.
Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.
Hirata M, Harihara Y, Kita Y, Saito S, Nishimuraj M, Yoshino H
Dig Dis Sci. 2002; 47(5):1100-6.
PMID: 12018907
DOI: 10.1023/a:1015050410041.